Tranylcypromine has been approved in the United States

Studies listed may include approved and non-approved uses, formulations or treatment regimens. Before prescribing any product mentioned in this Register, healthcare Professionals should consult prescribing information approved in their country (view UK and US information for Healthcare Professionals).

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.

tranylcypromine studies

Select the study ID number to view the trial summary

Study ID	Phase	Title
385/004	I	Randomized, 2-way crossover, bioequivalence study of tranylcypromine sulfate 10mg tablets: Parnate® film-coated tablets of GlaxoSmithKline USA and Parnate® sugar-coated tablets of GlaxoSmithKline Canada administered as 1 x 10mg film-coated tablet or sugar-coated tablet in healthy subjects under fasting conditions.